Beaufort note out this morning on Research Tree.. "The Board has proposed DDD's AIM cancellation with a view to eliminating costs. While its SmartCam 2D digital technology product is highly innovative and has the potential to attract an active following, to date its subscription-based revenue model has failed to gain reasonable traction. Meanwhile, the Company's TriDef 2D to 3D conversion solution is rapidly losing momentum. Having secured additional patents to protect its proposed new 2D offerings, however, DDD is likely to remain cash hungry for some time to come. Given also the Board's recent decision to resort to the issuance of Secured Loan Notes to raise required working capital, its decision may be considered expedient in view of likely continuing funding needs and difficulty experienced in securing new equity funding. Given that the AIM-cancellation was proposed by DDD's Board, it is realistic to expect the Resolution to be successfully passed. Bearing this in mind, and the fact that it may in the future become difficult to trade DDD shares on the proposed basis of 'match bargain', shareholders might consider taking advantage of higher market trading liquidity between now and 6th July, should they wish to reduce of their holdings."
"RedHat had a decent print with its Q1 ahead of consensus after the US close last night; however, a 1% FY EPS reduction resulted in a share price down c5%. Despite the share price over-reaction, the news is of interest to Micro Focus shareholders as SUSE (the other Linux distribution, which competes with Red Hat) is benefitting from the same demand side driver – ie the secular growth in open source software usage. At some stage Kevin Loosemore, CEO Micro Focus, will ‘do something’ with SUSE – a big cUS$1bn payday for shareholders." Panmure note out this morning on research tree
finnCap note out this morning on research tree "Cambridge Cognition announced that it has signed an agreement with MANUS Neurodynamica, a UK-based healthcare technology company, to sell the MANUS Parkinson’s Pen for the diagnosis and monitoring of neuromotor impairments such as Parkinson’s in academic research, pharmaceutical clinical trials and occupational health markets."
carclo, not caretech. bloody dtm search :@
"The FY16 results showed that the core businesses of Technical Plastics and LED Technologies are continuing to grow revenues and expand margins. Management talks with enthusiasm about driving Technical Plastics into exciting new production technologies, and in LED Technologies the win of a medium volume sports car programme could lead to a significant increase in revenues and profits in the medium term. However, in our view, the relative earnings multiples still do not fully reflect the quality and potential of these business..." Edison note out, taken frm researchtree
Two broker notes out today, FirstEnergy Capital & finnCap, both on research tree... FirstEnergy Capital: "Market reaction: positive. We view the pipeline export solution for Stella as being very good news. This has historically been a source of concern for us given the risk of downtime associated to weather. Exporting through a pipeline would boost uptime and will reduce opex/boe by US$1.5/boe. In addition, this will likely result in an increase of recoverable reserves (lower cost implies longer economical life of the field). The change over from tankers to pipeline in 2017 is expected to result in minimal down time." finnCap: "Ahead of today’s AGM, the company has provided an update on its operations at Stella. The sail away of FPF-1 is expected either at the end of June or early July. The company has also gained access to an export pipeline. Stella update. It is encouraging to see that commissioning activities at FPF-1 are reaching a close and sail away is imminent."
FirstEnergy Capital put out a note this morning on research tree.. "Market Reaction: slightly negative on the reduced production, however the gas acts as feedstock to two other power stations and we expect a limited impact on our valuation if the dispute is resolved soon as the Company expects. Clarity on the program in Mozambique is welcome news, particularly as there are no obligations. The shares continue to offer a combination of value and immunity to oil price movements."